Literature DB >> 26219296

Pre-procedural assessment of aortic annulus dimensions for transcatheter aortic valve replacement: comparison of a non-contrast 3D MRA protocol with contrast-enhanced cardiac dual-source CT angiography.

Philipp Ruile1, Philipp Blanke2, Tobias Krauss3, Stephan Dorfs1, Bernd Jung4, Nikolaus Jander1, Jonathon Leipsic2, Mathias Langer3, Franz-Josef Neumann1, Gregor Pache5.   

Abstract

AIMS: To evaluate the feasibility of a non-contrast three-dimensional (3D)-FLASH magnetic resonance angiography (MRA) protocol for pre-procedural aortic annulus assessment for transcatheter aortic valve replacement (TAVR) in comparison with cardiac dual-source computed tomography angiography (CTA). METHODS AND
RESULTS: In this prospective study, 69 of 104 consecutive patients (mean age 81.8 ± 5.4 years, 37.7% arrhythmic) with severe aortic stenosis who had undergone pre-TAVR cardiac CTA received a respiratory and ECG-triggered, non-contrast 3D-FLASH MRA at 3 T. Annular area measurements were obtained at mid-diastole for both modalities whereas maximum systolic area was assessed by CTA only. Systolic MRA dimensions were modelled, by adding the relative difference of systolic and diastolic CTA area dimensions as a corrective factor. Hypothetical prosthesis sizing was performed based on systolic CTA, diastolic, and modelled systolic MRA area measurements. MR image quality and degree of annular calcifications were evaluated using 4-point-grading scales. The mean acquisition time was 14 ± 4.2 min. The mean image quality was 3.1 ± 0.9 with only two examinations rated non-diagnostic. The mean degree of calcifications was equal. As assessed by Bland-Altman analysis, there was no relevant systematic difference between area measurements for modelled systolic MRA and systolic CTA [the mean difference -3.1 mm(2) (limits of agreement -44.4 mm(2); 38.2 mm(2))]. Agreement for hypothetical prosthesis sizing was found in 63 of 67 (94%) patients for systolic CTA and modelled systolic MRA.
CONCLUSION: The employed non-contrast 3D-FLASH MRA protocol allows for reliable assessment of aortic annulus dimensions and calcifications even in the presence of arrhythmias in an all-comers pre-TAVR population. Implementation of this technique appears legitimate in patients at an increased risk for contrast-induced nephropathy. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  TAVI; TAVR; computed tomography; magnetic resonance angiography; transcatheter aortic valve replacement

Mesh:

Substances:

Year:  2015        PMID: 26219296     DOI: 10.1093/ehjci/jev188

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  18 in total

Review 1.  [Interventional therapy of aortic valve stenosis in Germany].

Authors:  C W Hamm; T Bauer
Journal:  Internist (Berl)       Date:  2016-04       Impact factor: 0.743

2.  Optimal pre-TAVR annulus sizing in patients with bicuspid aortic valve: area-derived perimeter by CT is the best-correlated measure with intraoperative sizing.

Authors:  Yuan Wang; Moyang Wang; Guanyuan Song; Wei Wang; Bin Lv; Hao Wang; Yongjian Wu
Journal:  Eur Radiol       Date:  2018-06-20       Impact factor: 5.315

3.  Cardiovascular magnetic resonance as a reliable alternative to cardiovascular computed tomography and transesophageal echocardiography for aortic annulus valve sizing.

Authors:  Riccardo Faletti; Marco Gatti; Stefano Salizzoni; Laura Bergamasco; Rodolfo Bonamini; Domenica Garabello; Walter Grosso Marra; Michele La Torre; Mara Morello; Simona Veglia; Paolo Fonio; Mauro Rinaldi
Journal:  Int J Cardiovasc Imaging       Date:  2016-04-27       Impact factor: 2.357

Review 4.  Role of Imaging in Transcatheter Aortic Valve Replacement.

Authors:  Corinna Storz; Tobias Geisler; Mike Notohamiprodjo; Konstantin Nikolaou; Fabian Bamberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-10

5.  Is MRI equivalent to CT in the guidance of TAVR? A pilot study.

Authors:  Agnes Mayr; Gert Klug; Sebastian J Reinstadler; Hans-Josef Feistritzer; Martin Reindl; Christian Kremser; Christof Kranewitter; Nikolaos Bonaros; Guy Friedrich; Gudrun Feuchtner; Bernhard Metzler
Journal:  Eur Radiol       Date:  2018-05-07       Impact factor: 5.315

6.  Different CMR Imaging Modalities for Native and Patch-Repaired Right Ventricular Outflow Tract Sizing: Impact on Percutaneous Pulmonary Valve Replacement Planning.

Authors:  Irene Ferrari; Nerejda Shehu; Naira Mkrtchyan; Stefan Martinoff; Andreas Eicken; Heiko Stern; Peter Ewert; Christian Meierhofer
Journal:  Pediatr Cardiol       Date:  2019-12-19       Impact factor: 1.655

7.  Ferumoxytol MRA for transcatheter aortic valve replacement planning with renal insufficiency.

Authors:  Kimberly Kallianos; Travis S Henry; Yerem Yeghiazarians; Jeffrey Zimmet; Kendrick A Shunk; Elaine E Tseng; Vaikom Mahadevan; Michael D Hope
Journal:  Int J Cardiol       Date:  2016-12-30       Impact factor: 4.164

8.  Gated thoracic magnetic resonance angiography at 3T: noncontrast versus blood pool contrast.

Authors:  Chengcheng Zhu; Henrik Haraldsson; Kimberly Kallianos; Liang Ge; Elaine Tseng; Travis Henry; David Saloner; Michael D Hope
Journal:  Int J Cardiovasc Imaging       Date:  2017-09-13       Impact factor: 2.357

Review 9.  Vascular Imaging Before Transcatheter Aortic Valve Replacement (TAVR): Why and How?

Authors:  Damiano Caruso; Russell D Rosenberg; Carlo N De Cecco; Stefanie Mangold; Julian L Wichmann; Akos Varga-Szemes; Daniel H Steinberg; Andrea Laghi; U Joseph Schoepf
Journal:  Curr Cardiol Rep       Date:  2016-02       Impact factor: 2.931

10.  Accuracy of cardiac magnetic resonance generated 3D models of the aortic annulus compared to cardiovascular computed tomography generated 3D models.

Authors:  Marco Gatti; Aurelio Cosentino; Erik Cura Stura; Laura Bergamasco; Domenica Garabello; Giovanni Pennisi; Mattia Puppo; Stefano Salizzoni; Simona Veglia; Ottavio Davini; Mauro Rinaldi; Paolo Fonio; Riccardo Faletti
Journal:  Int J Cardiovasc Imaging       Date:  2020-05-30       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.